Editorial

November 30, 2023


Summarizing the Intentions and Outcomes of JUO 2023 Issue 3
Cheol Kwak
J Urol Oncol. 2023;21(3):181-182.

Invited Review

November 30, 2023


Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma
Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, et al.
J Urol Oncol. 2023;21(3):183-199.

Topic Article

November 30, 2023


Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis
Jin Noh, Sang Hun Song, Gyoohwan Jung, et al.
J Urol Oncol. 2023;21(3):200-207.

Invited Review

November 30, 2023


The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects
Hyerim Ha, Joo Han Lim
J Urol Oncol. 2023;21(3):208-216.

Invited Review

November 30, 2023


Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
Chan Woo Wee, Jaeho Cho
J Urol Oncol. 2023;21(3):217-227.

Invited Review

November 30, 2023


Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
Jiwoong Yu, Hyun Hwan Sung
J Urol Oncol. 2023;21(3):228-240.

Topic Article

November 30, 2023


Early Experience With Pembrolizumab in Bacillus Calmette-Guérin Unresponsive Non–Muscle-Invasive Bladder Cancer
Chung Un Lee, Wan Song, Minyong Kang, et al.
J Urol Oncol. 2023;21(3):241-248.

Original Article

November 30, 2023


Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy
Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, et al.
J Urol Oncol. 2023;21(3):249-256.

Topic Article

November 30, 2023


Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Jaeyoung Cho, Jungyo Suh, Dalsan You, et al.
J Urol Oncol. 2023;21(3):257-263.

Topic Article

November 30, 2023


Nonregional Lymph Node Metastasis as a Predictor of Early Progression When Using Androgen Receptor Targeting Agents in Patients With Metastatic Castration-Resistant Prostate Cancer Without Previous Chemotherapy
Sihyeon Kim, Beom Yong Rho, Dong Hyuk Kang, et al.
J Urol Oncol. 2023;21(3):264-270.

Original Article

November 30, 2023


Negative Delta-Prostate-Specific Antigen Time Ratio as Potential New Marker of Progression-Free Survival in Castration-Resistant Prostate Cancer Patients Treated With First-Line Enzalutamide or Docetaxel
Tae Hwan Kim, Seol Ho Choo, Kang Hee Shim, et al.
J Urol Oncol. 2023;21(3):271-276.

Erratum: Addition of the second author

November 30, 2023


Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer
Ja Yoon Ku, Md Nazmul Huda, Eu Chang Hwang, et al.
J Urol Oncol. 2023;21(3):277-277.
Utility of Next-Generation Sequencing for Deciphering Intratumor Heterogeneity in Prostate Cancer  (4,314 times)
Je-Gun Joung, Joo-Young Park, So-Yun Yang, et al.
Korean J Urol Oncol. 2021;19(2):101-108.

Review Article

May 31, 2021

Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer  (4,174 times)
Jaemin Jo, Sanghoon Han, Jung-Sik Huh
Korean J Urol Oncol. 2021;19(1):23-29.

Review Article

Feb 26, 2021

The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment  (4,010 times)
Da Som Choi, Su Jeong Kang, In Ho Chang, et al.
Korean J Urol Oncol. 2021;19(1):30-39.

Review Article

Feb 26, 2021

Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 2 of 2  (3,981 times)
Amit Ghose, Makarand Khochikar, Ravindra Sabnis, et al.
Korean J Urol Oncol. 2021;19(1):1-15.

Review Article

Feb 26, 2021

Laparoscopic Radical Cystectomy With Intracorporeal Orthotopic Neobladder Reconstruction: An Initial Experience of Modified Studer Reconstruction Techniques  (3,942 times)
Jeong Ho Kim
Korean J Urol Oncol. 2021;19(2):117-123.

Case Report

May 31, 2021

Patient-Specific Tumor Microenvironment Models  (3,851 times)
Jung Woo Lee, Jia Kim, Youngjae Shin, et al.
Korean J Urol Oncol. 2021;19(4):197-222.Correction in: J Urol Oncol 2022;20(1):69

Review Article

Nov 25, 2021

Clinical Implications of Urinary Microbiome in Bladder Cancer  (3,312 times)
Jae Hun Shim, Joon Hee Gook, In Ho Chang, et al.
Korean J Urol Oncol. 2021;19(2):71-78.

Review Article

May 31, 2021

New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer  (3,284 times)
Jaewoon Jeong, Jae Baek Ha, In Ho Chang
Korean J Urol Oncol. 2022;20(1):12-24.

Review Article

Feb 24, 2022

Serum Testosterone Level as Possible Predictive Marker for Prognosis in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Enzalutamide  (3,219 times)
Dong Hyeon An, Hwiwoo Kim, Donghyun Lee, et al.
Korean J Urol Oncol. 2021;19(1):60-69.

Original Article

Feb 26, 2021

The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer  (3,187 times)
Jae Young Joung, Sung Han Kim
Korean J Urol Oncol. 2022;20(1):1-11.

Review Article

Feb 24, 2022

The Real-World Experience of Single-Center, Retrospective Study of the Prognostic Effect of Secondary Hormone Agent on Survival in Patients With Hormone-Refractory Metastatic Prostate Cancer  (3,118 times)
Sung Han Kim, Done-Eun Lee, Ho Kyung Seo, et al.
Korean J Urol Oncol. 2021;19(1):48-59.

Original Article

Feb 26, 2021

The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model  (3,048 times)
Seok Ju Hong, Gwang Yong Hwang, Su Jeong Kang, et al.
Korean J Urol Oncol. 2021;19(1):40-47.

Original Article

Feb 26, 2021

Coffee Consumption and Risk of Prostate Cancer in Local, Advanced, and Fatal Grades: A Meta-Epidemiological Study of Prospective Cohort Studies  (2,995 times)
Jong-Myon Bae
Korean J Urol Oncol. 2021;19(1):16-22.

Review Article

Feb 26, 2021

Microbiome of Genitourinary Tumors: Especially in Prostate Cancer and Kidney Cancer  (2,958 times)
Kyungchan Min, Seok Joong Yun, Hansoo Park, et al.
Korean J Urol Oncol. 2021;19(3):136-147.

Review Article

Aug 31, 2021

An Update of Gonadotropin-Releasing Hormone Antagonists in the Treatment of Advanced Prostate Cancer  (2,947 times)
Jeong Hee Hong
Korean J Urol Oncol. 2021;19(2):79-91.

Review Article

May 31, 2021

Predictive Factors for Acute Urinary Retention After Transperineal Template-Guided Mapping Biopsy  (2,869 times)
Si Hyun Sung, Chung Un Lee, Jae Hoon Chung, et al.
Korean J Urol Oncol. 2021;19(3):148-154.

Original Article

Aug 31, 2021

Construction of a Retrospective Cohort to Observe 10-Year Urologic Cancer Treatment Trends at the Biggest Medical Center of South Korea  (2,834 times)
Se Young Choi, Ho Heon Kim, Bumjin Lim, et al.
Korean J Urol Oncol. 2021;19(4):232-243.

Original Article

Nov 25, 2021

Usefulness of Prostate-Specific Antigen Density as an Indicator for Recommending Prebiopsy Magnetic Resonance Imaging to Prevent Missed Prostate Cancer Diagnoses  (2,772 times)
Jin Hyung Jeon, Kyo Chul Koo, Byung Ha Chung, et al.
Korean J Urol Oncol. 2021;19(3):155-163.

Original Article

Aug 31, 2021

Investigation of Information Acquisition Channel for Prostate Cancer High-Risk Group  (2,765 times)
Yun-Sok Ha, Kwang Taek Kim, Wook Nam, et al.
Korean J Urol Oncol. 2021;19(3):174-182.

Original Article

Aug 31, 2021

Predictive Factors of De Novo Overactive Bladder After Radical Prostatectomy in Patients With Clinically Localized Prostate Cancer: A Prospective Observational Study  (2,709 times)
Jun Nyung Lee, Sang Won Kim, Kyeong-Hyeon Byeon, et al.
Korean J Urol Oncol. 2021;19(2):109-116.

Original Article

May 31, 2021

Machine Learning Techniques in Prostate Cancer Diagnosis According to Prostate-Specific Antigen Levels and Prostate Cancer Gene 3 Score  (2,655 times)
Roberto Passera, Stefano De Luca, Cristian Fiori, et al.
Korean J Urol Oncol. 2021;19(3):164-173.

Original Article

Aug 31, 2021

Gastric Leiomyoma Misdiagnosed as a Left Cystic Adrenal Tumor  (2,567 times)
Young-Joo Kim
Korean J Urol Oncol. 2021;19(3):193-196.

Case Report

Aug 31, 2021

The Present and Future of Intravesical Therapy in Bladder Cancer  (2,551 times)
Sin-Woo Seong, Youngjae Shin, In Ho Chang, et al.
Korean J Urol Oncol. 2022;20(2):82-91.

Review Article

May 26, 2022

Utility of Urinalysis as a Follow-up Surveillance Tool in Nonmuscle Invasive Bladder Cancer  (2,483 times)
Minuk Park, Bumjin Lim, Dalsan You, et al.
Korean J Urol Oncol. 2021;19(4):244-251.

Original Article

Nov 25, 2021

Percutaneous Renal Tumor Biopsy in Small Renal Masses  (2,480 times)
Heejo Yang, Kihong Kim, Younsoo Jeon
Korean J Urol Oncol. 2021;19(2):92-100.

Review Article

May 31, 2021

Risk Factors Leading to Radical Cystectomy in Patients Who Had Undergone Nephroureterectomy  (2,480 times)
Janghui Lee, Bumjin Lim, Dalsan You, et al.
Korean J Urol Oncol. 2021;19(4):271-280.

Original Article

Nov 25, 2021

Perioperative and Oncological Outcomes of 1,002 Consecutive Patients With Localized Renal Cell Carcinoma Treated by Robotic Partial Nephrectomy at a Single Center  (2,428 times)
Taejin Kim, Jae Hoon Chung, Hyun Hwan Sung, et al.
Korean J Urol Oncol. 2021;19(3):183-192.

Original Article

Aug 31, 2021

Recurrent Bleeding From Ileal Conduit Stomal Varices in a Patient With Portal Hypertension  (2,323 times)
Jae-Wook Chung, Yun-Sok Ha, Jun Nyung Lee, et al.
Korean J Urol Oncol. 2021;19(2):124-126.

Case Report

May 31, 2021

Subcutaneous Interleukin-2 Monotherapy for Metastatic Renal Cell Carcinoma in Korean Patients  (2,259 times)
Jeong Ho Kim, Ki Soo Lee, Choung-Soo Kim, et al.
Korean J Urol Oncol. 2021;19(4):252-260.

Original Article

Nov 25, 2021

Small Renal Mass Biopsy: When to Do?  (2,233 times)
Jin Seon Cho
Korean J Urol Oncol. 2021;19(3):129-135.

Review Article

Aug 31, 2021

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043


Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org                

Copyright © The Korean Urological Oncology Society.

Developed in M2PI